Sahajanand Medical Technologies IPO
Sahajanand Medical Technologies opens for subscription on 15 Oct 2026 and closes on 19 Oct 2026, at a price band of ₹327 – ₹344 with a lot of 43 shares. Listing is expected on 23 Oct 2026.
Updated 22 Oct 2026
Important dates
Opens
15 Oct 2026
Closes
19 Oct 2026
Allotment
21 Oct 2026
Listing
23 Oct 2026
IPO details
| Price band | ₹327 – ₹344 |
|---|---|
| Lot size | 43 shares |
| Minimum investment | ₹14,792 |
| Issue size | ₹475.5 crore |
| Face value | ₹1 per share |
| Board | Mainboard |
| Listing at | BSE, NSE |
| Retail quota | 35% |
| EPS | ₹6.67 |
| RoNW | 10.6% |
Grey market premium (GMP)
Last reported GMP: ₹15 (4.4%), an unofficial estimated listing price near ₹359 or about ₹645 per lot.
GMP is unregulated grey market chatter, not an exchange price, and it often swings or turns out wrong on listing day. SEBI cautions investors against relying on it. Read the GMP explainer.
Subscription status
Subscribed 0.83 times overall at the last update.
| Day | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Day 1 | 0.37× | 0.2× | 0.41× | 0.35× |
| Day 2 | 1.12× | 0.51× | 0.83× | 0.83× |
| Day 3 | 1.12× | 1.3× | 1.13× | 1.14× |
How many lots can you apply for?
At the upper price band. Retail bids go up to ₹2 lakh, small NII (sHNI) above ₹2 lakh up to ₹10 lakh, and big NII (bHNI) above ₹10 lakh.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 43 | ₹14,792 |
| Retail (max) | 13 | 559 | ₹1,92,296 |
| sHNI (min) | 14 | 602 | ₹2,07,088 |
| sHNI (max) | 67 | 2,881 | ₹9,91,064 |
| bHNI (min) | 68 | 2,924 | ₹10,05,856 |
See IPO categories explained for how allotment works in each.
Company financials (₹ crore)
| Year | Revenue | Expenses | Profit after tax |
|---|---|---|---|
| FY24 | 908.59 | 875.5 | 7.35 |
| FY25 | 1,035.96 | 980.12 | 25.15 |
| FY26 | 1,218.73 | 1,138.43 | 69.08 |
About Sahajanand Medical Technologies
Incorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention. The company was the first globally to achieve CE certification for a drug-eluting stent (DES) with a biodegradable polymer, Infinnium. Its product range is divided into 3 main categories: Vascular Intervention (VI), Structural Heart (SH), and other products.
Sahajanand operates two R&D centers, one in India & one in Thailand, backed by a team of 102 professionals such as biomedical engineers and clinical research specialists. Moreover, its key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies and are widely known in over 76 countries across Europe, Asia, and other regions.
Objects of the issue
- TBA
Allotment status and registrar
MUFG Intime India Pvt. Ltd. is the registrar. After 21 Oct 2026, check your status with your PAN or application number on the registrar's site or the BSE/NSE allotment pages.
Registrar contact: 022-49186000 · sahajanandmedical.ipo@in.mpms.mufg.com
Lead managers and offer documents
- Motilal Oswal Investment Advisors Ltd.
- Avendus Capital Pvt.Ltd.
- HSBC Securities & Capital Markets (India) Pvt.Ltd.
- Nuvama Wealth Management Ltd.
Sahajanand Medical Technologies IPO: FAQs
When does the Sahajanand Medical Technologies IPO open and close?
The Sahajanand Medical Technologies IPO opens on 15 Oct 2026 and closes on 19 Oct 2026.
What is the Sahajanand Medical Technologies IPO price band?
The price band is ₹327 – ₹344 per share (face value ₹1).
What is the Sahajanand Medical Technologies IPO lot size?
One lot is 43 shares, so the minimum investment is ₹14,792 at the upper price band.
When is the Sahajanand Medical Technologies IPO allotment date?
Allotment is expected on 21 Oct 2026. Check the status on the registrar's site (MUFG Intime India Pvt. Ltd.) or the BSE/NSE allotment pages using your PAN.
When will Sahajanand Medical Technologies shares list?
Listing is expected on 23 Oct 2026 on BSE, NSE.
What is the Sahajanand Medical Technologies IPO GMP today?
The grey market premium was about ₹15 (4.4%) when this page was last updated, implying an unofficial estimated listing near ₹359. GMP is unregulated and can change quickly; do not rely on it.
Details are compiled from the offer documents and exchange disclosures via IPOWatch and may change or contain errors; verify in the RHP and on BSE/NSE before applying. This page is for information only and is not a recommendation to apply. Neminath Traders is not a SEBI-registered investment adviser. Read how to apply for an IPO.